EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Global prevalence of hereditary hemorrhagic telangiectasia-associated variants estimated by analysis of large-scale genomic databases

Eleonora Gaetani, Agnese Giovannetti, Luigi Di Martino, Niccolò Liorni, Viviana Caputo, Antonio Gasbarrini, Roberto Pola, Tommaso Mazza

Journal of Thrombosis and Haemostasis · 2026-09 · 24 (9) · 3325-3332

DOI: 10.1016/j.jtha.2025.12.025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-09. Verfasst von Eleonora Gaetani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hereditary Hemorrhagic Telangiectasia Center, Fondazione Policlinico Universitario Agostino Gemelli Istituto di ricovero e cura a carattere scientifi…. Hauptthemen laut MEDLINE: Telangiectasia, Hereditary Hemorrhagic, Endoglin, Activin Receptors, Type II, Mutation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder with an overwhelming hemorrhagic phenotype. It is mainly caused by variants in the ENG and ACVRL1 genes. HHT prevalence is currently estimated to be 1 in 5000 individuals, but the disease is likely underdiagnosed due to variable clinical presentation, misdiagnosis, and delayed recognition. OBJECTIVES: To estimate the global genetic prevalence of HHT-associated variants in ENG and ACVRL1. METHODS: We analyzed 3 large population-scale genomic databases: gnomAD, All of Us, and Regeneron Genetics Center-Million Exome. We considered known pathogenic and likely pathogenic variants of ENG and ACVRL1 and extended the analysis to potentially pathogenic variants passing the pathogenic criteria established by the guidelines for HHT of the American College of Medical Genetics and Genomics/Association for Molecular Pathology. RESULTS: The genetic prevalence of HHT ranged from 1.753 to 2.555 in 5000 individuals, when considering only pathogenic and likely pathogenic variants, and from 2.874 to 4.327 in 5000 individuals, when also potentially pathogenic variants were considered. CONCLUSION: This study assesses the prevalence of HHT-associated variants in the general population. Our unbiased approach demonstrates that the genetic prevalence of the disease is substantially higher than currently estimated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Telangiectasia, Hereditary HemorrhagicEndoglinActivin Receptors, Type IIMutationGenetic VariationHumansPrevalenceDatabases, GeneticGenetic Predisposition to DiseasePhenotypeGlobal HealthGenomics

Stichwörter der Autor:innen

genetic analysisglobal prevalencehereditary hemorrhagic telangiectasia

Substanzen

EndoglinENG protein, humanACVRL1 protein, humanActivin Receptors, Type II

Autor:innen und Institutionen

  • Hereditary Hemorrhagic Telangiectasia Center, Fondazione Policlinico Universitario Agostino Gemelli Istituto di ricovero e cura a carattere scientifico (IRCCS), Rome, Italy; Department of Translational Medicine and Surg…
  • Unità Operativa Semplice Computational Biology and Bioinformatics, Fondazione Policlinico Universitario Agostino Gemelli Istituto di ricovero e cura a carattere scientifico (IRCCS), Rome, Italy.
  • Hereditary Hemorrhagic Telangiectasia Center, Fondazione Policlinico Universitario Agostino Gemelli Istituto di ricovero e cura a carattere scientifico (IRCCS), Rome, Italy; Unità Operativa Complessa di Medicina Interna…
  • Department of Experimental Medicine, La Sapienza University of Rome, Rome, Italy.
  • Hereditary Hemorrhagic Telangiectasia Center, Fondazione Policlinico Universitario Agostino Gemelli Istituto di ricovero e cura a carattere scientifico (IRCCS), Rome, Italy; Percorso Trombosi, Department of Aging, Ortho…

Zitieren

APA

Gaetani, E., Giovannetti, A., Di Martino, L., Liorni, N., Caputo, V., Gasbarrini, A., Pola, R., & Mazza, T. (2026). Global prevalence of hereditary hemorrhagic telangiectasia-associated variants estimated by analysis of large-scale genomic databases. Journal of Thrombosis and Haemostasis, 24(9), 3325-3332. https://doi.org/10.1016/j.jtha.2025.12.025

Vancouver

Gaetani E, Giovannetti A, Di Martino L, Liorni N, Caputo V, Gasbarrini A, et al. Global prevalence of hereditary hemorrhagic telangiectasia-associated variants estimated by analysis of large-scale genomic databases. Journal of Thrombosis and Haemostasis. 2026;24(9):3325-3332. doi:10.1016/j.jtha.2025.12.025

BibTeX
@article{Gaetani2026,
  author = {Gaetani, Eleonora and Giovannetti, Agnese and Di Martino, Luigi and Liorni, Niccolò and Caputo, Viviana and Gasbarrini, Antonio and Pola, Roberto and Mazza, Tommaso},
  title = {Global prevalence of hereditary hemorrhagic telangiectasia-associated variants estimated by analysis of large-scale genomic databases},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  volume = {24},
  number = {9},
  pages = {3325--3332},
  doi = {10.1016/j.jtha.2025.12.025}
}
Kostenlos starten →